Cytogenetics in multiple myeloma:: A multicenter study of 24 patients with t(11;14)(q13;q32) or its variant

被引:32
作者
Laï, JL
Michaux, L
Dastugue, N
Vasseur, F
Daudignon, A
Facon, T
Bauters, F
Zandecki, M
机构
[1] Hop Jeanne de Flandres, Med Genet Lab, F-59037 Lille, France
[2] UCL Belg, Lab Cytogenet, Bruxelles, Belgium
[3] CHU Toulouse, Lab Cytogenet, Toulouse, France
[4] CHU Lille, Fac Med, CNRS EP10, Lab Genet Malad Multifactorielles, F-59037 Lille, France
[5] CHU Valenciennes, Dept Hematol & Cytogenet, Valenciennes, France
[6] CHU Lille, Serv Malad Sang, F-59037 Lille, France
[7] CHU Lille, Hop Calmette, Lab Hematol A, F-59037 Lille, France
关键词
D O I
10.1016/S0165-4608(97)00469-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Twenty-two patients with multiple myeloma (MM) with a classical t(11;14)(q13;q32) and two complex variants also involving 11q13 and 14q32 regions are reported. We show that t(11;14) (q13;q32) is predominantly noticed in stages II and III and never in stage I patients. Translocation (11;14)(q13;q32) is predominantly observed in hypodiploid or pseudodiploid clones associated with total or partial monosomy of chromosome 13 and additional structural changes in chromosome 1. These translocations may be discovered not only in standard cultures (24-48 hours) without stimulation, but also in cytokine-stimulated cultures (granulocyte macrophage colony-stimulating factor and interleukin 6). The t(11;141)(q13;q32) as a primary or secondary event in MM is discussed, because, in one patient, it was only discovered at relapse. (C) Elsevier Science Inc., 1998.
引用
收藏
页码:133 / 138
页数:6
相关论文
共 34 条
[1]   NONRANDOM KARYOTYPE ABNORMALITIES IN 36 MULTIPLE-MYELOMA PATIENTS [J].
ANKATHIL, R ;
MADHAVAN, J ;
GANGADHARAN, VP ;
PILLAI, GR ;
NAIR, MK .
CANCER GENETICS AND CYTOGENETICS, 1995, 83 (01) :71-74
[2]   ANALYSIS OF G-BANDED KARYOTYPES IN MYELOMA CELLS [J].
CHEN, KC ;
BEVAN, PC ;
MATTHEWS, JG .
JOURNAL OF CLINICAL PATHOLOGY, 1986, 39 (03) :260-266
[3]   Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines [J].
Chesi, M ;
Bergsagel, PL ;
Brents, LA ;
Smith, CM ;
Gerhard, DS ;
Kuehl, WM .
BLOOD, 1996, 88 (02) :674-681
[4]  
DAO DD, 1994, LEUKEMIA, V8, P1280
[5]  
DEWALD GW, 1985, BLOOD, V66, P380
[6]  
Durie BGM, 1991, NEOPLASTIC DISEASES, P439
[7]   IMPROVED CYTOGENETIC ANALYSIS OF BONE-MARROW PLASMA-CELLS AFTER CYTOKINE STIMULATION IN MULTIPLE-MYELOMA - A REPORT ON 46 PATIENTS [J].
FACON, T ;
LAI, JL ;
NATAF, E ;
PREUDHOMME, C ;
ZANDECKI, M ;
HAMMAD, M ;
WATTEL, E ;
JOUET, JP ;
BAUTERS, F .
BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 (04) :743-745
[8]  
FERTI A, 1983, CANC GENET CYTOGENET, V12, P247
[9]  
FERTI G, 1984, ANN GENET, V27, P52
[10]  
FRUCHART C, 1995, 5 INT WORKSH MULT MY